Study on Sustainable China’s Pharmaceutical Innovation Ecosystem
DOI:
https://doi.org/10.54691/bcpbm.v19i.650Keywords:
China’s Pharmaceutical Innovation, Sustainable Innovation Ecosystem, Policy, Talent and Investment, Quality ControlAbstract
In recent years, China's pharmaceutical innovation has achieved remarkable results, with strong growth in innovative drug development driven by policy, talent, and investment. Through more than 20 years of development, China has initially established a relatively complete drug regulatory system of laws and regulations. At the same time, China's pharmaceutical innovation is also facing many challenges, including policy, talent, and investment. However, compared to the world's leading countries, there is still a gap in the quality of innovation in China's currently marketed pharmaceutical innovation ecosystem. By implementing the concept of scientific and risk-based assessment, this paper provides a comprehensive analysis of the current state of China's pharmaceutical innovation ecosystem and proposes future directions for development, including improving laws, regulations, policies, and technical guidelines promptly; improving the review decision-making mechanism and priority review mechanism to encourage the review of innovative drugs; optimising the organisational structure, approval process and resource allocation of regulatory bodies in a demand-driven manner to shorten the review time; and strengthening the clinical data.
Downloads
References
Aguilar, Twardowski, T., & Wohlgemuth, R. (2019). Bioeconomy for Sustainable Development. Biotechnology Journal, 14(8), e1800638–n/a. https://doi.org/10.1002/biot.201800638
Ahmed, Kyriakopoulos, G. L., Streimikiene, D., & Streimikis, J. (2021). Drivers of Proactive Environmental Strategies: Evidence from the Pharmaceutical Industry of Asian Economies. Sustainability (Basel, Switzerland), 13(16), 9479–. https://doi.org/10.3390/su13169479
Almaainah. (2021). Multiple Perspectives of a Knowledge-Based Innovation Ecosystem: The Case of Khalifa Fund for Enterprise Development in the UAE. ProQuest Dissertations Publishing.
Birch, Levidow, L., & Papaioannou, T. (2012). Self-Fulfilling Prophecies of the European Knowledge-Based Bio-Economy: The Discursive Shaping of Institutional and Policy Frameworks in the Bio-Pharmaceuticals Sector. Journal of the Knowledge Economy, 5(1), 1–18. https://doi.org/10.1007/s13132-012-0117-4
Chohra. (2019). A critical review of the academic entrepreneurial ecosystem in developing countries: The case of Algeria. The International Journal of Technology Management & Sustainable Development, 18(3), 243–259. https://doi.org/10.1386/tmsd_00008_1
Clavis Nwehfor Fubah, & Menisha Moos. (2022). Exploring COVID-19 Challenges and Coping Mechanisms for SMEs in the South African Entrepreneurial Ecosystem. Sustainability (Basel, Switzerland), 14(4), 1944–. https://doi.org/10.3390/su14041944
D’Amato, Bartkowski, B., & Droste, N. (2020). Reviewing the interface of bioeconomy and ecosystem service research. Ambio, 49(12), 1878–1896. https://doi.org/10.1007/s13280-020-01374-0
Ding. (2018). Pharma Industry 4.0: Literature review and research opportunities in sustainable pharmaceutical supply chains. Process Safety and Environmental Protection, 119, 115–130. https://doi.org/10.1016/j.psep.2018.06.031
Festa, Rossi, M., Kolte, A., & Marinelli, L. (2021). The contribution of intellectual capital to financial stability in Indian pharmaceutical companies. Journal of Intellectual Capital, 22(2), 337–359. https://doi.org/10.1108/JIC-03-2020-0091
Fu, Wu, F., & Zhang, S. (2022). Evolutionary Path and Innovative Development of Pharmaceutical Industrial Cluster-A Case Study of Shijiazhuang, China. International Journal of Environmental Research and Public Health, 19(5), 2928–. https://doi.org/10.3390/ijerph19052928
Harada, Wang, H., Kodama, K., & Sengoku, S. (2021). Drug Discovery Firms and Business Alliances for Sustainable Innovation. Sustainability (Basel, Switzerland), 13(7), 3599–. https://doi.org/10.3390/su13073599
Hui, Mohammed, B., Donyai, P., McCrindle, R., & Sherratt, R. S. (2020). Enhancing Pharmaceutical Packaging through a Technology Ecosystem to Facilitate the Reuse of Medicines and Reduce Medicinal Waste. Pharmacy, 8(2), 58–. https://doi.org/10.3390/pharmacy8020058
Jennifer Markarian. (2020). Improving Efficiency for Sustainable Pharmaceutical Facilities. Pharmaceutical Technology Europe, 32(3), 38–39.
Ma, Liu, Z., Huang, X., & Li, T. (2019). The Impact of Local Government Policy on Innovation Ecosystem in Knowledge Resource Scarce Region: Case Study of Changzhou, China. Science, Technology & Society (New Delhi, India), 24(1), 29–52. https://doi.org/10.1177/0971721818806096
Rosendal. (2006). Balancing Access and Benefit Sharing and Legal Protection of Innovations From Bioprospecting: Impacts on Conservation of Biodiversity. The Journal of Environment & Development, 15(4), 428–447. https://doi.org/10.1177/1070496506294799
Saneja, Panda, A. K., & Lichtfouse, E. (2020). Sustainable Agriculture Reviews 43 [electronic resource]: Pharmaceutical Technology for Natural Products Delivery Vol. 1 Fundamentals and Applications / edited by Ankit Saneja, Amulya K. Panda, Eric Lichtfouse. (1st ed. 2020.). Springer International Publishing. https://doi.org/10.1007/978-3-030-41838-0
Wadovski, Nogueira, R., & Chimenti, P. (2020). Genetic services diffusion in the precision medicine ecosystem. International Journal of Pharmaceutical and Healthcare Marketing, 14(4), 533–560. https://doi.org/10.1108/IJPHM-02-2019-0010
Yao, Li, H., Shang, D., & Ding, L. (2021). Evolution of the Industrial Innovation Ecosystem of Resource-Based Cities (RBCs): A Case Study of Shanxi Province, China. Sustainability (Basel, Switzerland), 13(20), 11350–. https://doi.org/10.3390/su132011350
Downloads
Published
Issue
Section
How to Cite
